3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth
Abbott Laboratories (ABT), Medtronic (MDT), and Becton Dickinson (BDX) recently raised their dividends, offering yields of 2.45%, 3.22%, and 2.28% respectively. Abbott, with a 54-year streak of dividend increases, reported strong cash flow and raised 2026 EPS guidance. Medtronic saw significant cash flow growth and strong revenue. BDX, post-spinoff, showed improved cash flow and beat earnings estimates.
How this was made
The 30-second read
Why it matters
The dividend increases may attract income‑focused investors, supporting modest price appreciation and sector rotation into healthcare dividend stocks.
Market read
Income‑oriented investors may rebalance toward these dividend kings, providing modest upside for the tickers.
What to watch
Exact Sciences acquisition debt and upcoming business separations could pressure future cash flow.
Background
The article profiles three long‑standing dividend‑paying medical‑device companies, detailing recent dividend hikes and cash‑flow metrics.
Ticker impact
Abbott announced a quarterly dividend increase to $0.63 per share, its 54th consecutive raise.
likely modest upside as yield‑focused buyers add positions
Higher dividend and solid free cash flow improve attractiveness without diluting equity.
Medtronic lifted its quarterly dividend to $0.72 per share, marking its 49th straight increase.
potential slight upside as income‑seeking investors rotate in
Yield increase is small but reinforces the company's dividend‑king narrative.
Becton Dickinson raised its quarterly dividend to $1.05 per share after spinning off its biosciences unit.
possible modest upside as the market prices the leaner structure and higher payout
Spin‑off reduces complexity and the dividend increase signals cash‑flow strength.
Market effects
Highlights the resilience of the medical‑device sector and may lift other dividend‑seeking stocks in the space.
U.S. market may see modest inflows into healthcare dividend funds.
Reinforces the appeal of dividend‑growth stocks worldwide, especially for retirees.
Counterpoint
Higher dividends could signal limited growth opportunities; investors might prefer capital‑appreciation plays.
Key entities
- companyAbbott Laboratories
Medical‑device and diagnostics firm with 54 consecutive dividend raises.
- companyMedtronic
Medical‑device maker with 49 consecutive dividend raises.
- companyBecton Dickinson
Medical‑device supplier that recently spun off its biosciences unit.
